SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla reached a new all-time high, fueling community discussions around its robotaxi strategy and battery expansion plans in Europe. Bullish sentiment appears strong, with some traders eyeing the $500 level and beyond, while others caution about stretched valuations and potential pullbacks. Discussions also include the company's long-term growth potential and competition in the EV market.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge to new highs, driven by speculation around supply constraints and increased industrial demand, particularly for AI data centers. The community is discussing potential for further gains, with some pointing to historical patterns and a possible shift in market dynamics as financial institutions adjust their positions. Concerns about market manipulation and the impact of COMEX margin hikes are also circulating among investors.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon's potential $10B investment from OpenAI to utilize its AI chips is a hot topic, fueling discussions about the data center sector and analysts' target prices. The community is analyzing Amazon's infrastructure and AWS re-acceleration, while some express concerns about the investment's impact and potential market reactions, viewing it as an AI "circle jerk."

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation surrounding potential rescheduling of cannabis, driven by reports of an upcoming executive order from President Trump, which has fueled significant trading volume. The community is closely watching for official confirmation, with many anticipating substantial gains if the rescheduling occurs, while some caution against potential pullbacks or dilution. Discussions range from short-term trading strategies to long-term investment perspectives, reflecting high interest in the cannabis sector's potential.

nLIGHT, Inc. engages in the provision of semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It operates through the Laser Products and Advanced Development segments. The Laser Products segment designs, manufactures, and sells a range of semiconductor lasers and fiber lasers that are typically integrated into laser systems or manufacturing tools built by customers. The Advanced Development segment focuses on research, design, and prototyping of next-generation laser technologies, leveraging expertise in laser technology, development, beam control, and advanced optics. The company was founded by Scott H. Keeney, Mark DeVito, and Jason Farmer in June 2000 and is headquartered in Camas, WA.

nLIGHT Inc

nLIGHT ($LASR) is trending as traders discuss its potential breakout, noting that it is coiling under resistance. Community members are watching for volume expansion to confirm a fresh trend in this mid-cap laser tech company. Some also point to possible defense contracts, such as the "Golden Dome", as a catalyst.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its recent merger and focus on robotics, with community members comparing it to past high-flying stocks. The stock's low float and high short interest are fueling speculation of a potential short squeeze, with many retail investors encouraging others to hold firm. Community members are actively discussing price targets and strategies to counter short sellers.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as users highlight its community-driven approach and its positioning as a culture coin on the Solana network, drawing comparisons to Bitcoin. Discussions also emphasize the potential benefits of cannabis and hemp within the biotech and environmental sectors, tying these broader themes to the token's future prospects. The community emphasizes the coins unique culture, building, creativity, and the plant's potential for healing.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as anticipation builds around potential cannabis rescheduling, fueled by reports of a possible executive order. The community is buzzing over the implications of rescheduling, particularly the potential for tax relief and increased institutional investment. Traders are closely watching for official confirmation and the resulting impact on US cannabis companies.

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. It also designs a robust clinical development program that includes ongoing clinical trials of Viaskin peanut, and Viaskin milk, as well as pre-clinical development of Viaskin egg. The company was founded by Pierre-Henri Benhamou, Stéphane Benhamou, Bertrand Dupont, Christophe Dupont, and Pierre-Yves Vannerom on March 29, 2002 and is headquartered in Chatillon, France.

DBV Technologies - ADR

DBV Technologies

DBV Technologies ($DBVT) is trending due to positive Phase 3 results for its VIASKIN Peanut patch, showing significant success in treating peanut allergies in children. The community is discussing the potential for FDA filing and the possibility of a squeeze, with attention focused on institutional buying and analyst target prices. Some investors are cautious, highlighting potential dilution risks and waiting for price confirmation.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending as silver prices test new highs, generating excitement about the company's potential profitability; the community is discussing the disconnect between silver's rise and AG's stock performance, as well as potential manipulation. Some are pointing to AG's long-term potential given the bullish outlook for silver and possible acquisitions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine and has a lead investigational...

Redmile Group LLC Cuts Stock Holdings in Stoke Therapeutics, Inc. $STOK

Redmile Group LLC lessened its position in shares of Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) by 2.5% in the second quarter, according to the company in its most recent 13F filing with...

Stoke Therapeutics (NASDAQ:STOK) General Counsel Jonathan Allan Sells 3,978 Shares of Stock

Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) General Counsel Jonathan Allan sold 3,978 shares of the stock in a transaction that occurred on Monday, December 8th. The shares were sold at...

Stoke Therapeutics (NASDAQ:STOK) Director Sells $433,386.10 in Stock

Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) Director Edward Md Kaye sold 13,430 shares of Stoke Therapeutics stock in a transaction on Monday, December 8th. The shares were sold at an...

Insider Selling: Stoke Therapeutics (NASDAQ:STOK) General Counsel Sells 3,978 Shares of Stock

Stoke Therapeutics, Inc. (NASDAQ:STOK - Get Free Report) General Counsel Jonathan Allan sold 3,978 shares of the business's stock in a transaction that occurred on Monday, December 8th. The shares...

Stoke Therapeutics' Chief Medical Officer Sold Over 5,000 Shares in the Company. Should Shareholders Sell?

Key PointsBarry Ticho, Chief Medical Officer of Stoke Therapeutics, sold 5,358 shares for a transaction value of $167,115.04 at a weighted average price of $31.19 per share in December...

Stoke Therapeutics (NASDAQ:STOK) Shares Up 12.4% - Time to Buy?

Stoke Therapeutics (NASDAQ:STOK) Stock Price Up 12.4% - Time to Buy...

Stoke Therapeutics (NASDAQ:STOK) Shares Down 5.1% - What's Next?

Stoke Therapeutics (NASDAQ:STOK) Shares Down 5.1% - Here's Why...

Marshall Wace LLP Acquires 168,771 Shares of Stoke Therapeutics, Inc. $STOK

Marshall Wace LLP lifted its stake in Stoke Therapeutics, Inc. (NASDAQ:STOK - Free Report) by 7.9% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange...

STOK Crosses Above Average Analyst Target

In recent trading, shares of Stoke Therapeutics Inc (Symbol: STOK) have crossed above the average analyst 12-month target price of $31.62, changing hands for $33.00/share. When a stock reaches the...

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. The company was founded by Isabel Aznarez and Adrian R. Krainer in June 2014 and is headquartered in Bedford, MA.

Stoke Therapeutics Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

STOK
Stoke Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest STOK News

STOKStoke Therapeutics Inc